SB 522 Pennsylvania Senate · 2021-2022 Regular Session

An Act providing for blood lead assessment and testing of certain children and pregnant women by health care providers; imposing duties on the Department of Health; and requiring certain health insurance policies to cover blood lead tests.

Bill status signed all 5 stages cleared

Introduction

Apr 2021

Committee Review

Oct 2022

Senate Passage

Oct 2022

House Passage

Oct 2022

Signed into Law

Nov 2022

Introduced Apr 9, 2021 Signed Nov 3, 2022

Floor votes · Senate Jun 13, 2022 · House Oct 26, 2022

How they voted

46–0

Passed · 1 other

Total votes 47

Jun 13, 2022

D Democratic20

20 Yea

100% Yea

I Independent1

1 Yea

100% Yea

R Republican26

25 Yea 1

96% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Nov 3, 2022

Signed into law

Approved by the Governor

upper

Oct 26, 2022

Upper · Passed

Senate concurred in House amendments

upper

Oct 26, 2022

Upper · Passed

Re-reported on concurrence, as committed

upper

Oct 26, 2022

Committee

Referred to RULES AND EXECUTIVE NOMINATIONS

upper

Oct 26, 2022

Lower · Passed

Third consideration and final passage

lower

Oct 26, 2022

Lower · Passed

Re-reported as amended

lower

Oct 26, 2022

Lower · Passed

PN 2009 Amended in House Committee on APPROPRIATIONS

lower

Oct 25, 2022

Committee

Re-referred to APPROPRIATIONS

lower

Sep 21, 2022

Lower · Passed

PN 1935 Reported as amended

lower

Jun 14, 2022

Committee

Referred to CHILDREN AND YOUTH

lower

Jun 13, 2022

Upper · Passed

Third consideration and final passage

upper

Jun 13, 2022

Introduced

PN 1747 Amended on third consideration

upper

Jun 6, 2022

Upper · Passed

Re-reported as committed

upper

Feb 7, 2022

Committee

Re-referred to APPROPRIATIONS

upper

Dec 14, 2021

Upper · Passed

PN 1275 Reported as amended

upper

Apr 9, 2021

Committee

PN 0542 Referred to HEALTH AND HUMAN SERVICES

upper

1 primary · 12 co-sponsors